multiple-sclerosis

Documents about multiple-sclerosis

• Effects of Physical Therapy and Dalfampridine on Functional Mobility in Non Ambulatory Persons With Multiple Sclerosis#895969ClinicalTrials.gov
• Effect of Tai Chi on Balance, Mood, Cognition, and Quality of Life in Patients With Multiple Sclerosis#896527ClinicalTrials.gov
• Biological Activity and Safety of Low Dose IL2 in Relapsing Remitting Multiple Sclerosis#915807ClinicalTrials.gov
• Normative Modelling of Brain Volume in Multiple Sclerosis#158291bioRxiv / medRxiv
• Cortical Lesions Form Predominantly in Early Multiple Sclerosis#241499bioRxiv / medRxiv
• TENS in Persons With MS#836640ClinicalTrials.gov
• A Study for Tysabri Participant Preference#888414ClinicalTrials.gov
• Efficacy and Safety of BG00012 in MS#909841ClinicalTrials.gov
• Tysabri Observational Cohort Study - Multiple Sclerosis (MS) Registries#914250ClinicalTrials.gov
• MSPEECH (multiple sclerosis monitoring through speech interaction in clinic and at home): a Living Lab study protocol for co-created, speech-based digital biomarkers in multiple sclerosis.#418325NCBI PubMed Central
• Rule-based semi-automated method to segment black hole multiple sclerosis lesions on post-gadolinium 2D T1-weighted brain images#669688Europe PMC
• Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.#810507ClinicalTrials.gov
• Observational Study of the Prevalence of CCSVI in Multiple Sclerosis and in Other Neurodegenerative Diseases#813652ClinicalTrials.gov
• Measurement and Training of Dual-Task of Gait in Persons With Multiple Sclerosis#858129ClinicalTrials.gov
• Efficacy Study of Andrographis Paniculata Purified Standardized Extract (ApE) in Patients With Multiple Sclerosis (MS)#881270ClinicalTrials.gov
• Internet-based Physical Activity Promotion and Exercise Prescription for People With Multiple Sclerosis#894996ClinicalTrials.gov
• Effects of a Combined Supplementation of Conjugated Linoleic Acid (CLA) and Probiotics (Vivomixx®) as add-on to a First-line Immunotherapy in Relapsing-remitting Multiple Sclerosis#906589ClinicalTrials.gov
• A Study to Evaluate Pharmacokinetics, Safety, Tolerability, Immunogenicity and Pharmacodynamic Effects of Subcutaneous Ocrelizumab Administration in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)#915300ClinicalTrials.gov
• Study of Electrical Impedance Myography (EIM) in ALS#847252ClinicalTrials.gov
• A randomised controlled trial of internet-delivered cognitive behavioural therapy targeting symptoms of depression, anxiety and disability in adults with multiple sclerosis.#9625PubMed
• Cognitive-motor dual task to reveal gait impairments in multiple sclerosis patients at an early stage: A systematic review#284202HAL (France)
• The predictive value of serum neurofilament light chain levels beyond MRI measures for clinical and radiological disease progression in the earliest stages of multiple sclerosis#784498Europe PMC
• A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)#824953ClinicalTrials.gov
• Stimulation of Acupuncture Points in Female Patients With Multiple Sclerosis and Neurogenic Bladder Dysfunction#841310ClinicalTrials.gov
• Non-invasive Spinal Cord Stimulation for Spasticity Control and Augmentation of Voluntary Motor Control in Individuals With Multiple Sclerosis#842197ClinicalTrials.gov
• Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients#850969ClinicalTrials.gov
• MRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis#884449ClinicalTrials.gov
• Treating Multiple Sclerosis With Sirolimus, an Immune System Suppressor#891370ClinicalTrials.gov
• Factorial Optimization Trial to Test Cognitive Behavioral Therapy Components for Multiple Sclerosis Fatigue#900952ClinicalTrials.gov
• A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMS#917114ClinicalTrials.gov
• Effect of Artificial Intelligence Based Cognitive Training on Sleep Disorders and Quality of Life in Patients With Multiple Sclerosis#917399ClinicalTrials.gov
• Balance Targeted Exercises for Individuals With MS#812077ClinicalTrials.gov
• Oral Cladribine B-cell Study#828619ClinicalTrials.gov
• RNF and Betaseron® Tolerability Study#849541ClinicalTrials.gov
• Physical Disability in Patients Treated With Betaferon#874497ClinicalTrials.gov
• Cognitive and Emotion Regulation Training in MS#882201ClinicalTrials.gov
• Testing the Efficacy of Self-Generation Treatment Protocol#888155ClinicalTrials.gov
• TYSABRI Global Observational Program in Safety#888386ClinicalTrials.gov
• Neurofilaments for NEDA Assessing in MS#904874ClinicalTrials.gov
• Postoperative Relapses in MS Patients#916588ClinicalTrials.gov
• The role of pericytes in the pathophysiology multiple of sclerosis#955848Koc University Digital Collections
• Bile acids as candidate therapies for multiple sclerosis: inverse signal analysis using the FDA adverse event reporting system and preclinical validation#223136OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Impact of Exercise on "Invisible" Symptoms and Quality of Life in Multiple Sclerosis Individuals#801597ClinicalTrials.gov
• Assess Safety, Bio-distribution, Radiation Dosimetry and Optimize the Imaging Protocol of GEH120714 (18F) Injection in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS).#804567ClinicalTrials.gov
• Phase 3, 28-week, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of Nabiximols as an add-on Therapy in Subjects With Spasticity Due to Multiple Sclerosis.#831366ClinicalTrials.gov
• Effect of Cervical Mobilization on Balance and Plantar Pressure Distribution in Multiple Sclerosis#833592ClinicalTrials.gov
• Early Detection and Paramedical Care of Sexual Difficulties in Nervous System Diseases: Example of Multiple Sclerosis and Brain Tumors (NEUROSEX)#837205ClinicalTrials.gov
• A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)#851798ClinicalTrials.gov
• A Therapeutic Experience Program (TEP) Study for Improvement of Gait in People With Multiple Sclerosis (MS)#899550ClinicalTrials.gov
• Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis#900513ClinicalTrials.gov